Financhill
Sell
44

PLSE Quote, Financials, Valuation and Earnings

Last price:
$14.70
Seasonality move :
7.85%
Day range:
$14.65 - $15.45
52-week range:
$12.56 - $25.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
11,658.18x
P/B ratio:
11.03x
Volume:
156.2K
Avg. volume:
180.7K
1-year change:
-18.06%
Market cap:
$1B
Revenue:
--
EPS (TTM):
-$1.14
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue -- $1.4M $700K -- --
Revenue Growth (YoY) -- -- -50.64% -100% --
 
Cost of Revenues $1.1M $3.1M $13.3M $1.2M $1.2M
Gross Profit -$1.1M -$1.7M -$12.6M -$1.2M -$1.2M
Gross Profit Margin -- -119.61% -1797.29% -- --
 
R&D Expenses $26.4M $28.6M $20.6M $27.8M $32.3M
Selling, General & Admin $22.9M $33.8M $26M $15.8M $23.9M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $48.9M $61.3M $45.5M $42.4M $53.2M
Operating Income -$50M -$63M -$58.1M -$43.6M -$54.4M
 
Net Interest Expenses -- $646K $448K $1.1M --
EBT. Incl. Unusual Items -$49.9M -$63.7M -$58.5M -$42.2M -$53.6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$49.9M -$63.7M -$58.5M -$42.2M -$53.6M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$49.9M -$63.7M -$58.5M -$42.2M -$53.6M
 
Basic EPS (Cont. Ops) -$2.14 -$2.28 -$1.72 -$0.88 -$0.92
Diluted EPS (Cont. Ops) -$2.14 -$2.28 -$1.72 -$0.88 -$0.92
Weighted Average Basic Share $23.2M $28M $33.9M $48M $58.4M
Weighted Average Diluted Share $23.2M $28M $33.9M $48M $58.4M
 
EBITDA -$48.9M -$61.9M -$56.7M -$42.4M -$53.2M
EBIT -$50M -$63M -$58.1M -$43.6M -$54.4M
 
Revenue (Reported) -- $1.4M $700K -- --
Operating Income (Reported) -$50M -$63M -$58.1M -$43.6M -$54.4M
Operating Income (Adjusted) -$50M -$63M -$58.1M -$43.6M -$54.4M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $574K -- -- -- $86K
Revenue Growth (YoY) -- -100% -- -- --
 
Cost of Revenues $994K $8.7M $266K $267K $535K
Gross Profit -$420K -$8.7M -$266K -$267K -$449K
Gross Profit Margin -73.17% -- -- -- -522.09%
 
R&D Expenses $6.5M $4.5M $7.5M $7.7M $11.4M
Selling, General & Admin $7.7M $5.1M $3.8M $6M $8.8M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $13.9M $9.3M $11M $13.4M $19.9M
Operating Income -$14.3M -$18M -$11.3M -$13.7M -$20.4M
 
Net Interest Expenses $9K $14K -- -- --
EBT. Incl. Unusual Items -$14.3M -$18M -$10.6M -$12.7M -$19.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$14.3M -$18M -$10.6M -$12.7M -$19.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$14.3M -$18M -$10.6M -$12.7M -$19.4M
 
Basic EPS (Cont. Ops) -$0.48 -$0.49 -$0.19 -$0.21 -$0.29
Diluted EPS (Cont. Ops) -$0.48 -$0.49 -$0.19 -$0.21 -$0.29
Weighted Average Basic Share $29.6M $37.2M $54.9M $61.1M $67.4M
Weighted Average Diluted Share $29.6M $37.2M $54.9M $61.1M $67.4M
 
EBITDA -$14M -$17.7M -$11M -$13.4M -$20.1M
EBIT -$14.3M -$18M -$11.3M -$13.7M -$20.4M
 
Revenue (Reported) $574K -- -- -- $86K
Operating Income (Reported) -$14.3M -$18M -$11.3M -$13.7M -$20.4M
Operating Income (Adjusted) -$14.3M -$18M -$11.3M -$13.7M -$20.4M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $574K $1.6M -$9K -- $86K
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $1.8M $13.2M $2.5M $1.1M $1.4M
Gross Profit -$1.3M -$11.7M -$2.5M -$1.1M -$1.3M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $30.4M $22.4M $24M $29.5M $44.5M
Selling, General & Admin $30.6M $32M $14.4M $19.1M $34.3M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $60.1M $53.1M $37.3M $47.4M $75.8M
Operating Income -$61.4M -$64.7M -$39.8M -$48.5M -$77.1M
 
Net Interest Expenses $640K $20K $1.6M -- --
EBT. Incl. Unusual Items -$62M -$64.7M -$39.5M -$46.1M -$74.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$62M -$64.7M -$39.5M -$46.1M -$74.7M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$62M -$64.7M -$39.5M -$46.1M -$74.7M
 
Basic EPS (Cont. Ops) -$2.32 -$2.03 -$0.92 -$0.81 -$1.14
Diluted EPS (Cont. Ops) -$2.32 -$2.03 -$0.92 -$0.81 -$1.14
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -$60.3M -$63.4M -$38.6M -$47.4M -$76M
EBIT -$61.4M -$64.7M -$39.8M -$48.5M -$77.1M
 
Revenue (Reported) $574K $1.6M -$9K -- $86K
Operating Income (Reported) -$61.4M -$64.7M -$39.8M -$48.5M -$77.1M
Operating Income (Adjusted) -$61.4M -$64.7M -$39.8M -$48.5M -$77.1M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $574K $709K -- -- $86K
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $1.5M $11.7M $870K $832K $1.1M
Gross Profit -$966K -$11M -$870K -$832K -$999K
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $23M $16.7M $19.9M $21.7M $33.8M
Selling, General & Admin $24.5M $22.6M $11M $14.3M $24.7M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $46.6M $38.3M $30.2M $35.2M $57.7M
Operating Income -$47.6M -$49.3M -$31M -$36M -$58.7M
 
Net Interest Expenses $640K $14K $1.1M -- --
EBT. Incl. Unusual Items -$48.2M -$49.3M -$30.3M -$34.2M -$55.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$48.2M -$49.3M -$30.3M -$34.2M -$55.3M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$48.2M -$49.3M -$30.3M -$34.2M -$55.3M
 
Basic EPS (Cont. Ops) -$1.78 -$1.51 -$0.68 -$0.59 -$0.82
Diluted EPS (Cont. Ops) -$1.78 -$1.51 -$0.68 -$0.59 -$0.82
Weighted Average Basic Share $82.2M $98.4M $136.8M $173.4M $201.8M
Weighted Average Diluted Share $82.2M $98.4M $136.8M $173.4M $201.8M
 
EBITDA -$46.8M -$48.3M -$30.2M -$35.2M -$57.9M
EBIT -$47.6M -$49.3M -$31M -$36M -$58.7M
 
Revenue (Reported) $574K $709K -- -- $86K
Operating Income (Reported) -$47.6M -$49.3M -$31M -$36M -$58.7M
Operating Income (Adjusted) -$47.6M -$49.3M -$31M -$36M -$58.7M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $20.5M $28.6M $61.1M $44.4M $118M
Short Term Investments $8M -- -- -- --
Accounts Receivable, Net -- $61K -- -- --
Inventory -- $5.8M -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets $1.9M $2.1M $1M $963K $1.4M
Total Current Assets $22.3M $36.6M $62.1M $45.3M $119.4M
 
Property Plant And Equipment $11.9M $11.2M $10M $8.8M $8.3M
Long-Term Investments -- -- -- -- --
Goodwill $2.8M $2.8M $2.8M $2.8M $2.8M
Other Intangibles $3.9M $3.2M $2.6M $1.9M $1.2M
Other Long-Term Assets $365K $365K $365K $365K $677K
Total Assets $44.9M $57.5M $80.6M $60.8M $134.1M
 
Accounts Payable $1.7M $2.9M $1.6M $1.8M $1.7M
Accrued Expenses $2M $1.5M $1.2M $615K $2.2M
Current Portion Of Long-Term Debt -- -- $917K -- --
Current Portion Of Capital Lease Obligations $542K $774K $896K $1.1M $1.4M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $7.6M $8.5M $6M $6.7M $10.1M
 
Long-Term Debt $10.8M $10M $74.1M $8.1M $7.5M
Capital Leases -- -- -- -- --
Total Liabilities $22M $21.8M $82.9M $16.4M $19.2M
 
Common Stock $25K $29K $37K $55K $66K
Other Common Equity Adj -$1K -- -- -- --
Common Equity $22.9M $35.7M -$2.2M $44.4M $114.9M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $22.9M $35.7M -$2.2M $44.4M $114.9M
 
Total Liabilities and Equity $44.9M $57.5M $80.6M $60.8M $134.1M
Cash and Short Terms $20.5M $28.6M $61.1M $44.4M $118M
Total Debt $10.8M $10.5M $75.1M $8.1M $7.5M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Cash and Equivalents $42M $69.2M $50.4M $79M $95.2M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $72K $5K -- -- $15K
Inventory $4.3M $750K -- -- $57K
Prepaid Expenses -- -- -- -- --
Other Current Assets $2.9M $1.2M $1.2M $1.4M --
Total Current Assets $49.2M $71.2M $51.6M $80.4M $97.2M
 
Property Plant And Equipment $11.4M $10.5M $9.1M $7.8M $7.4M
Long-Term Investments -- -- -- -- --
Goodwill $2.8M $2.8M $2.8M $2.8M --
Other Intangibles $3.4M $2.7M $2.1M $1.4M --
Other Long-Term Assets $365K $365K $365K $646K --
Total Assets $67.1M $87.6M $65.9M $93M $108.8M
 
Accounts Payable $2.7M $2M $1.4M $1.7M $3M
Accrued Expenses $1.4M $1M $749K $710K --
Current Portion Of Long-Term Debt $1.1M $98K -- -- --
Current Portion Of Capital Lease Obligations $749K $858K $1M $1.2M --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $9.5M $7M $5.4M $6.7M $9.7M
 
Long-Term Debt $10.2M $74.4M $8.4M $7.2M $6.4M
Capital Leases -- -- -- -- --
Total Liabilities $19.8M $81.4M $13.8M $13.9M $16.1M
 
Common Stock $29K $37K $55K $62K $68K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $47.4M $6.2M $52.1M $79.1M $92.7M
 
Total Liabilities and Equity $67.1M $87.6M $65.9M $93M $108.8M
Cash and Short Terms $42M $69.2M $50.4M $79M $95.2M
Total Debt $11.3M $74.5M $8.4M $7.2M $6.4M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$49.9M -$63.7M -$58.5M -$42.2M -$53.6M
Depreciation & Amoritzation $1.1M $1.1M $1.4M $1.2M $1.2M
Stock-Based Compensation $10.1M $14.6M $5.2M $7.2M $13.6M
Change in Accounts Receivable -- -$7K $20K $109K $48K
Change in Inventories -- -$5.8M -$2.7M -- -$31K
Cash From Operations -$35.4M -$54.1M -$47M -$33M -$36.3M
 
Capital Expenditures $441K $437K $401K $121K $125K
Cash Acquisitions -- -- -- -- --
Cash From Investing $10M $7.6M -$401K -$121K -$125K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- $1.9M $65M -- --
Long-Term Debt Repaid -- -$1.5M -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -$232K -$437K -$6K -$281K
Cash From Financing $30.9M $62.7M $79.9M $16.4M $110.1M
 
Beginning Cash (CF) $12.5M $28.6M $61.1M $44.4M $118M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $5.6M $16.2M $32.5M -$16.8M $73.7M
Ending Cash (CF) $18M $44.8M $93.7M $27.6M $191.7M
 
Levered Free Cash Flow -$35.8M -$54.5M -$47.4M -$33.2M -$36.5M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders -$14.3M -$18M -$10.6M -$12.7M -$19.4M
Depreciation & Amoritzation $287K $339K $299K $294K $256K
Stock-Based Compensation $1.6M $723K $1.8M $3M $5.6M
Change in Accounts Receivable -$63K -$20K $8K $4K -$15K
Change in Inventories -$1.6M -$250K -- -- -$6K
Cash From Operations -$13.4M -$10.6M -$10.5M -$9M -$13M
 
Capital Expenditures $157K $62K $23K $38K $62K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$157K -$62K -$23K -$38K -$62K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $209K $65M -- -- --
Long-Term Debt Repaid -$875K -- $1.7M -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -$1K $56K --
Cash From Financing $8.1M $65.1M $2.2M $61.9M $2M
 
Beginning Cash (CF) $42M $69.2M $50.4M $79M $95.2M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$5.4M $54.4M -$8.4M $52.8M -$11.1M
Ending Cash (CF) $36.6M $123.5M $42M $131.9M $84.1M
 
Levered Free Cash Flow -$13.5M -$10.7M -$10.5M -$9.1M -$13.1M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders -$62M -$64.7M -$39.5M -$46.1M -$74.7M
Depreciation & Amoritzation $1.1M $1.3M $1.2M $1.2M $1.1M
Stock-Based Compensation $13.4M $8.1M $4.6M $10.1M $23.3M
Change in Accounts Receivable -$40K $36K $131K $2K $12K
Change in Inventories -$4.3M -$3.8M -$356K -- --
Cash From Operations -$50.7M -$51.7M -$34.2M -$34M -$48.5M
 
Capital Expenditures $582K $494K $119K $115K $283K
Cash Acquisitions -- -- -- -- --
Cash From Investing $21.9M -$494K -$119K -$115K -$283K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $1.9M -- -- -- --
Long-Term Debt Repaid -$875K -$1.1M $437K -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $63.7M $79.4M $15.6M $62.7M $65M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $34.9M $27.2M -$18.8M $28.6M $16.2M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$51.2M -$52.2M -$34.3M -$34.1M -$48.8M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders -$48.2M -$49.3M -$30.3M -$34.2M -$55.3M
Depreciation & Amoritzation $849K $1M $903K $891K $812K
Stock-Based Compensation $11M $4.4M $3.8M $6.8M $16.5M
Change in Accounts Receivable -$40K $3K $114K $7K -$29K
Change in Inventories -$4.3M -$2.3M -- -- -$57K
Cash From Operations -$41.4M -$39M -$26.3M -$27.2M -$39.4M
 
Capital Expenditures $303K $360K $78K $72K $230K
Cash Acquisitions -- -- -- -- --
Cash From Investing $7.7M -$360K -$78K -$72K -$230K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $1.9M $65M -- -- --
Long-Term Debt Repaid -$875K -$437K $0 -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$232K -- -$6K -$222K --
Cash From Financing $63.2M $80M $15.6M $61.9M $16.8M
 
Beginning Cash (CF) $149.3M $96.6M $163.2M $140.1M $320.8M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $29.5M $40.5M -$10.8M $34.7M -$22.8M
Ending Cash (CF) $178.8M $137.2M $152.5M $174.8M $298M
 
Levered Free Cash Flow -$41.7M -$39.4M -$26.3M -$27.3M -$39.6M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
65
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Buy
51
Is GOOGL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
70
RGC alert for Jan 8

Regencell Bioscience Holdings Ltd. [RGC] is down 21.5% over the past day.

Buy
64
RVMD alert for Jan 8

Revolution Medicines, Inc. [RVMD] is up 4.61% over the past day.

Sell
38
CRNX alert for Jan 8

Crinetics Pharmaceuticals, Inc. [CRNX] is down 0.23% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock